Novartis Venture Fund Investors
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Invests into
.jpg)
Zip:
NA
Acquisitions Number:
NA
Investors Number:
NA
Estimated Revenue:
107.46 USD
Employee Number:
11-50
Investment Stage:
Early Stage Venture, Late Stage Venture, Post-Ipo, Secondary Market, Seed
Industry:
Innovation, Technology, and Research
Founded Date:
1996-01-01
Headquarters:
Basel, Basel-Stadt, Switzerland
Number Of Exists:
67
Investor Type:
Not Classified
Funding Status:
N/A